J&J doses return in low volume as vaccine demand wanes
Julia Bergman and Amada Cuda
April 26, 2021
FacebookTwitterEmail
In this file photo taken on March 3, 2021, a vial of the Johnson & Johnson COVID-19 vaccine is viewed at Hartford Hospital in Hartford, Connecticut.Joseph Prezioso / Getty Images
The return of the Johnson & Johnson vaccine following a temporary pause will likely have little impact on the COVID-19 vaccine rollout in Connecticut, which is seeing waning demand.
Several Connecticut providers said they are not relying on the resumption of the J&J vaccine to meet their numbers. The state is hoping the “one and done” vaccine will still appeal to those who, before the pause, expressed interest in it for that reason.
Three weeks into COVID-19 vaccinations, DOC has vaccinated 10 percent of inmates, 40 percent of staff
Kelan Lyons, CTMirror.org
FacebookTwitterEmail
HVIZDAK ph722a # 3174 New Haven, Connecticut-11/15/07: New Haven Community Correctional Center main entrance.
Three weeks into the Department of Correction’s vaccinations of the incarcerated population, 837 inmates less than 10% of the 9,034 people in prisons and jails as of Feb. 22 have received the first dose of the COVID-19 vaccine.
The department received another 500 doses Tuesday morning. Department Director of External Affairs Karen Martucci said the DOC has used all of the shots it has received and is seeking more.
“We roll them out as they come in,” said Martucci.